We are live on ! Find out more
AEON.WS

AEON Biopharma Inc
AEON.WS

Delisted

AEON.WS was delisted on the 26th of April, 2024.

Back to rankings

49 hedge funds and large institutions have $2.87M invested in AEON Biopharma Inc in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

6% less funds holding

Funds holding: 52 → 49 (-3)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

49% less capital invested

Capital invested by funds: $5.62M → $2.87M (-$2.76M)

Holders
49
Holders Change
-3
Holders Change %
-5.77%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
2
Closed
10
Calls
$352K
Puts
–
Net Calls
+$352K
Net Calls Change
-$662K

Top Buyers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
+$17.3K
2
UOC
UBS O'Connor
Illinois
+$6.49K
3
PC
Periscope Capital
Ontario, Canada
+$4.76K
4
LIM
Longfellow Investment Management
Massachusetts
+$3.74K
5
SG
StoneX Group
New York
+$2.92K

Top Sellers

Rank Fund Capital Flow
1
HIM
HGC Investment Management
Ontario, Canada
-$4K
2
RA
Ramius Advisors
New York
-$3K
3
Citadel Advisors
Citadel Advisors
Florida
-$2.7K
4
FIG
Fortress Investment Group
New York
-$2.1K
5
GPCM
Granite Point Capital Management
Massachusetts
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$2.03M – – –
AC
2
Athos Capital
Hong Kong
$302K – – –
SCM
3
Segantii Capital Management
Hong Kong
$169K – – –
Parallax Volatility Advisers
4
Parallax Volatility Advisers
California
$47.3K -$842 -14,590 -2%
SCM
5
Shaolin Capital Management
Florida
$40K +$17.3K +299,517 +70%
CF
6
Cantor Fitzgerald
New York
$32.8K – – –
PC
7
Periscope Capital
Ontario, Canada
$28.5K +$4.76K +82,566 +19%
AC
8
Aristeia Capital
Connecticut
$21.9K – – –
RCM
9
Radcliffe Capital Management
Pennsylvania
$18.9K – – –
DKCM
10
Davidson Kempner Capital Management
New York
$18.7K – – –
DKP
11
Davidson Kempner Partners
New York
$18.7K +$21.2K +366,671 New
CAC
12
Cowen and Company
New York
$15.6K +$962 +16,666 +6%
TCM
13
Tenor Capital Management
New York
$9.17K – – –
UOC
14
UBS O'Connor
Illinois
$7.38K +$6.49K +112,473 New
QGA
15
Q Global Advisors
Texas
$7K – – –
BNP Paribas Financial Markets
16
BNP Paribas Financial Markets
France
$6.36K – – –
Hudson Bay Capital Management
17
Hudson Bay Capital Management
Connecticut
$6K – – –
Calamos Advisors
18
Calamos Advisors
Illinois
$5.46K – – –
KL
19
KIM LLC
Kansas
$5.46K – – –
Wells Fargo
20
Wells Fargo
California
$5.21K – – –
WA
21
Whitebox Advisors
Minnesota
$5.06K – – –
CCA
22
Castle Creek Arbitrage
Colorado
$4.68K – – –
Goldman Sachs
23
Goldman Sachs
New York
$4.37K – – –
Balyasny Asset Management
24
Balyasny Asset Management
Illinois
$4.37K – – –
CH
25
CVI Holdings
Delaware
$4.33K -$1.67K -28,935 -27%
1
2 3

AEON.WS Hedge Fund Activity: Q1 2023 in Review

49 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma Inc (AEON.WS) for Q1 2023, worth a combined $2.87M — down 49% from $5.62M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of AEON.WS and 8 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 7 added.

The largest buyer was Shaolin Capital Management, adding an estimated $17.3K. The largest seller was HGC Investment Management, exiting entirely with an estimated $4K sold.

  • 49 institutional investors held AEON Biopharma Inc (AEON.WS) as of Q1 2023, down from 52 in Q4 2022.
  • Funds reported $2.87M of AEON Biopharma Inc stock for Q1 2023, down 49% quarter-over-quarter.
  • 8 funds opened new AEON Biopharma Inc positions in Q1 2023 and 10 closed out, a net change of -2 holders.
  • The largest AEON Biopharma Inc buyer in Q1 2023 was Shaolin Capital Management, an estimated $17.3K added.
  • The largest AEON Biopharma Inc seller in Q1 2023 was HGC Investment Management, an estimated $4K sold.

Based on aggregated 13F filings for Q1 2023.